Early FVRCP Vaccination Tied to Lower Mortality in Shelter Kittens

Kittens vaccinated against feline viral rhinotracheitis, calicivirus and panleukopenia before four weeks of age showed markedly lower mortality than kittens vaccinated later or not at all, according to a five-year retrospective cohort study published in BMC Veterinary Research. Among 397 neonatally vaccinated kittens admitted to a high-volume municipal shelter, 90-day all-cause mortality was 7 percent (29 of 397), compared with 15 percent (200 of 1,311) among kittens that did not receive a neonatal dose, a risk ratio of 0.48 (95 percent confidence interval 0.33 to 0.70, p less than 0.001).

Adjusted for age at intake and intake year, with litter-level cluster-robust standard errors, the model yielded a hazard ratio of 0.51 (95 percent confidence interval 0.28 to 0.93, p = 0.028) for 90-day all-cause mortality. All pre-specified sensitivity analyses produced point estimates favoring vaccination, and the direction of the association was consistent across all five years of data and across modeling approaches.

Vaccination of kittens younger than four weeks has remained controversial because of concerns about safety, immunologic immaturity and interference from maternal antibodies.

Thirteen panleukopenia cases were documented during the study period, twelve of which occurred across three litter-level outbreaks. The authors report these details as part of a broader assessment of infectious disease burden in neonatal shelter kittens, a group that faces high mortality from infectious diseases in shelter environments.

The observational design imposes important limits on interpretation. A retrospective cohort study of records from a single shelter cannot establish causation, and unmeasured differences between vaccinated and unvaccinated kittens could contribute to the observed association. The authors note that the consistency of the association in direction across all five years and across modeling approaches strengthens the observation, but they call for prospective multi-site studies to confirm the findings.

The study’s structure reflects a methodological challenge common in neonatal vaccination research: kittens that die before reaching the standard vaccination age of four weeks can never enter the standard-vaccinated group, which can bias simple comparisons.

The practical implication drawn by the authors is targeted rather than sweeping. They conclude that the findings support consideration of vaccinating shelter kittens on entry before four weeks of age in high-risk settings, while emphasizing that prospective multi-site research is warranted before broader practice change. The population studied was kittens admitted to one municipal shelter, so generalization to other settings, such as private veterinary practices with lower disease pressure, is not established by these data.

For shelter medicine, the results add quantitative evidence to a long-running debate over the timing of the first FVRCP dose in neonatal animals. The reported combination of a roughly halved 90-day mortality risk, adjusted hazard ratio of 0.51, and no documented vaccine-attributed adverse events across nearly 400 neonatally vaccinated kittens represents, within the limits of a retrospective single-site design, the central empirical contribution of the study.

Subject of Research: Neonatal FVRCP vaccination and mortality in shelter kittens

Article Title: Neonatal FVRCP vaccination was associated with lower 90-day mortality and no detected adverse events in shelter kittens: a 5-year retrospective cohort study

Article References: Kreisler, R., Aziz, C., & O’Quin, J. (2026). Neonatal FVRCP vaccination was associated with lower 90-day mortality and no detected adverse events in shelter kittens: a 5-year retrospective cohort study. BMC Veterinary Research. https://doi.org/10.1186/s12917-026-06026-1

Image Credits: AI Generated

DOI: 10.1186/s12917-026-06026-1

Keywords: shelter kittens, FVRCP vaccine, neonatal vaccination, retrospective cohort study, feline panleukopenia, 90-day mortality, vaccine safety, animal shelter, veterinary research, Cox model, Neonatal, FVRCP